Youlei Wang

427 total citations
11 papers, 345 citations indexed

About

Youlei Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Youlei Wang has authored 11 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Youlei Wang's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer-related molecular mechanisms research (4 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Youlei Wang is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Cancer-related molecular mechanisms research (4 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Youlei Wang collaborates with scholars based in China and United States. Youlei Wang's co-authors include Jinjin Zhang, Xiaodong Song, Changjun Lv, Jie Zhang, Songzi Zhang, Qingyin Zheng, Pan Xu, Huizhu Liu, Wenbo Liu and Meirong Wang and has published in prestigious journals such as Brain Research, Cell Death and Disease and Journal of Cellular and Molecular Medicine.

In The Last Decade

Youlei Wang

11 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youlei Wang China 11 176 125 108 37 28 11 345
Linbo Yuan China 13 218 1.2× 130 1.0× 88 0.8× 51 1.4× 18 0.6× 21 383
Bin-bin Wan China 10 237 1.3× 136 1.1× 102 0.9× 40 1.1× 40 1.4× 13 416
Wen Tian China 13 152 0.9× 56 0.4× 60 0.6× 21 0.6× 31 1.1× 28 327
Jie Jian China 9 171 1.0× 57 0.5× 84 0.8× 21 0.6× 104 3.7× 14 357
Eman K. Habib Egypt 11 192 1.1× 25 0.2× 115 1.1× 25 0.7× 46 1.6× 24 371
Sonia Tyagi United States 8 156 0.9× 57 0.5× 52 0.5× 60 1.6× 70 2.5× 13 376
Zherui Shen China 13 251 1.4× 175 1.4× 97 0.9× 24 0.6× 22 0.8× 24 419
Anmei Shu China 9 211 1.2× 83 0.7× 61 0.6× 47 1.3× 35 1.3× 13 402
Lijuan Xie China 8 169 1.0× 39 0.3× 95 0.9× 17 0.5× 50 1.8× 13 336

Countries citing papers authored by Youlei Wang

Since Specialization
Citations

This map shows the geographic impact of Youlei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youlei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youlei Wang more than expected).

Fields of papers citing papers by Youlei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youlei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youlei Wang. The network helps show where Youlei Wang may publish in the future.

Co-authorship network of co-authors of Youlei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Youlei Wang. A scholar is included among the top collaborators of Youlei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youlei Wang. Youlei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Chen, Hongbin, Jing Wang, Rongrong Li, et al.. (2020). Astaxanthin attenuates pulmonary fibrosis through lncITPF and mitochondria‐mediated signal pathways. Journal of Cellular and Molecular Medicine. 24(17). 10245–10250. 19 indexed citations
3.
Zhang, Jie, et al.. (2018). Astilbin ameliorates pulmonary fibrosis via blockade of Hedgehog signaling pathway. Pulmonary Pharmacology & Therapeutics. 50. 19–27. 25 indexed citations
4.
Li, Hongbo, Zhenkai Wang, Jie Zhang, et al.. (2018). Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway. BMC Complementary and Alternative Medicine. 18(1). 234–234. 21 indexed citations
5.
Li, Rongrong, Youlei Wang, Xiaodong Song, et al.. (2018). Potential regulatory role of circular RNA in idiopathic pulmonary fibrosis. International Journal of Molecular Medicine. 42(6). 3256–3268. 58 indexed citations
6.
Liu, Huizhu, Jinjin Zhang, Songzi Zhang, et al.. (2017). A novel lnc-PCF promotes the proliferation of TGF-β1-activated epithelial cells by targeting miR-344a-5p to regulate map3k11 in pulmonary fibrosis. Cell Death and Disease. 8(10). e3137–e3137. 42 indexed citations
7.
Gao, Yulin, Jinjin Zhang, Yuxia Liu, et al.. (2017). Regulation of TERRA on telomeric and mitochondrial functions in IPF pathogenesis. BMC Pulmonary Medicine. 17(1). 163–163. 32 indexed citations
8.
Wang, Youlei, Jinjin Zhang, Meng Han, et al.. (2016). SMND-309 promotes neuron survival through the activation of the PI3K/Akt/CREB-signalling pathway. Pharmaceutical Biology. 54(10). 1982–1990. 23 indexed citations
9.
Zhang, Jinjin, Pan Xu, Youlei Wang, et al.. (2015). Astaxanthin prevents pulmonary fibrosis by promoting myofibroblast apoptosis dependent on Drp1‐mediated mitochondrial fission. Journal of Cellular and Molecular Medicine. 19(9). 2215–2231. 58 indexed citations
10.
Zhang, Jinjin, et al.. (2011). Rosmarinic Acid Inhibits Proliferation and Induces Apoptosis of Hepatic Stellate Cells. Biological and Pharmaceutical Bulletin. 34(3). 343–348. 37 indexed citations
11.
Tian, Jingwei, Fenghua Fu, Guisheng Li, et al.. (2009). SMND-309, a novel derivate of salvianolic acid B, ameliorates cerebral infarction in rats: Characterization and role. Brain Research. 1263. 114–121. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026